Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Novel methods and technologies for the evaluation of drug outcomes and policies
As a leading Open Access publisher, Frontiers is committed to empowering not only scientists, but other researchers, innovators and members of the public. As such, highlighting sustainable development and the real-world applications of Drugs Outcomes Research & Policies are a key part to the agenda of Frontiers in Pharmacology. This Research Topic aims to highlight advancements in Health Economics and Outcomes Research (HEOR) techniques, methods and tools used by the pharmaceutical industry and other non-academic bodies.
Healthcare Funding and Christian Ethics
Healthcare has an impact on everyone, and healthcare funding decisions shape how and what healthcare is provided. In this book, Stephen Duckett outlines a Christian, biblically grounded, ethical basis for how decisions about healthcare funding and priority-setting ought to be made. Taking a cue from the parable of the Good Samaritan (Luke 10:25-37), Duckett articulates three ethical principles drawn from the story: compassion as a motivator; inclusivity, or social justice as to benefits; and responsible stewardship of the resources required to achieve the goals of treatment and prevention. These are principles, he argues, that should underpin a Christian ethic of healthcare funding. Duckett's book is a must for healthcare professionals and theologians struggling with moral questions about rationing in healthcare. It is also relevant to economists interested in the strengths and weaknesses of the application of their discipline to health policy.
Guidelines for the Prevention Care and Treatment of Persons with Chronic Hepatitis B Infection
These are the first World Health Organization (WHO) guidelines for the prevention care and treatment of persons living with CHB infection and complement similar recent published guidance by WHO on the prevention care and treatment of infection due to the hepatitis C virus (HCV). In contrast to several recent international guidelines on the management of CHB infection from the United States Europe Asia-Pacific and the United Kingdom (UK) the primary audience for these WHO guidelines is country programme managers in all settings but particularly in LMICs to help plan the development and scale up of hepatitis B prevention care and treatment. These guidelines are also intended for health-care pr...
